MANUFACTURING

MANUFACTURING HIGHLIGHTS

Versatile

  • TBX-3400 can be manufactured on a variety of sterile, enclosed systems.

  • Pre-programmed protocols are uploaded to the instrument and processing requires minimal human oversight.

Reliable

  • Clinical products have met specification with a 97.5% success rate.

  • Over 80 products have been manufactured to-date, with only 2 failures, both due to operator error.

Low Cost

  • TBX-3400’s manufacturing process is fast, simple, and has a low cost structure. Below highlights the primary costs incurred to manufacture a course of treatment of TBX-3400.

KEYS OF CRYOPRESERVATION

Cryopreservation of TBX-3400 provides significant financial and logistical advantages.

  • Up to 16 doses of TBX-3400 can be made from one manufacturing run.
     

  • Cells have over 70% viability post-thaw.
     

  • Stability data up to 24 months and increasing with additional time-points.

manufacture_edited.jpg